Breaking News

Pillar5 Pharma Expands Operations

August 23, 2013

Receives $1M from Eastern Ontario Development Fund

Pillar5 Pharma, Inc. has received $1 million from the Eastern Ontario Development Fund (EODF) to expand production at its Arnprior manufacturing facility, creating 56 new jobs and retaining 94 more in the community.
 
With support from EODF, Pillar5 will increase its operations by installing two new, advanced production lines for the manufacturing and packaging of eye care products. This expansion will better position the company to pursue new markets, both at home and abroad.
 
Dr. Eric Hoskins, Minister of Economic Development, Trade and Employment, said, “We are proud to be supporting job creation right here in eastern Ontario. This investment will help Pillar5 become a leader in the production of eye care products while expanding their markets and bringing new jobs and prosperity to the community of Arnprior.”
 
Kevin Rampton, chief executive officer of Pillar5 Pharma, commented, “We are thankful for the support from the Ontario government. This expansion means we can offer our customers more solutions for their pharmaceutical outsourcing needs. It also gives us greater capacity to increase production and explore new markets.”

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

blog comments powered by Disqus
  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision

  • The Impact of Sample Handling  and Processing on the Outcome of Bioanalytical Testing

    The Impact of Sample Handling and Processing on the Outcome of Bioanalytical Testing

    Haiko Pillu, Head Technical Operations, Life Science Services, SGS Belgium NV||September 8, 2016
    Optimizing bioanalytical procedures to get reliable results in clinical studies

  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture